According to a study published in May 2018 in the journal Thyroid, metformin, a medication commonly used to help people with newly diagnosed type 2 diabetes watch their blood sugar levels, and also helps prevent thyroid cancer. Scientists from Gyeongsang National University and other research institutions in the Republic of Korea have found fewer thyroid cancers in people who have been prescribed metformin than non-users. It was also found that higher doses of the diabetic drug are associated with a lower risk of developing cancer in the thyroid gland.
Researchers compared 128,453 metformin users with the same number of non-users for new cases of thyroid cancer. Users have been divided into ...
- low,
- medium and
- maximum amounts
- 340 users and
- 487 non-users
From the above information, it was concluded that the oral diabetic drug, metformin, reduce the risk of developing cancer in the thyroid gland. It has been proposed to use the drug both for lowering blood sugar levels and for its anti-cancer effects.
Metformin works to reduce blood sugar levels, reducing the amount of sugar absorbed in the digestive tract, reducing the amount of sugar excreted by the liver, and increasing insulin sensitivity ...
- in 2009, it was shown that insulin resistance is often present in patients diagnosed with thyroid cancer.
- in 2017, it was suggested that an increase in insulin resistance worldwide may cause an increase in the incidence of thyroid cancer.
- higher insulin resistance in a group of 201 participants who had lumps of the thyroid gland than a group of 308 individuals without cones.
- people with the highest insulin resistance had the greatest bruises of the thyroid gland.
In March 2018, Direct science Reported that the diabetic drug also helps DNA repair, another possible mechanism for cancer prevention. The drug is under investigation for treatment or prevention ...
- uterus,
- pancreas and
- mammary cancer
